Buy Theravance Biopharma Stock | TBPH Stock Price & Latest News | Public.com
TBPH

Theravance Biopharma

$0.00 (0.00%)Today
    View Theravance Biopharma (TBPH) stock trends here

    About TBPH

    Theravance Biopharma, Inc. operates as a biopharmaceutical company. It focuses on the discovery, research, development, and commercialization of organ-selective medicines. Its products include telavancin under the VIBATIV brand, revefenacin under the TD 4208 brand, and ...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.39
    -0.78
    -1.16
    Q2 2020
    Q3 2020
    Q4 2020
    Q1 2021

    Expected EPS
    Q1 2021

    -$1.07

    Actual EPS
    Q1 2021

    Stats

    Market Cap$1,11B
    Volume103
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$31.35
    1 Year Low$14.48
    Open$19.14
    High$19.14
    Low$17.13

    Buy any stock with any amount of money.

    Download the App
    Download the app